OBWG
VRTX icon

Onyx Bridge Wealth Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Onyx Bridge Wealth Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$221K Buy
494
+3
+0.6% +$1.4K 0.02% 331
2025
Q4 		$223K Buy
+491
New +$212K 0.02% 323
2024
Q4 		– Sell
-724
Closed -$337K – 302
2024
Q3 		$337K Buy
+724
New +$348K 0.05% 203

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Onyx Bridge Wealth Group's VRTX Position: Q1 2026 in Review

Onyx Bridge Wealth Group increased its Vertex Pharmaceuticals (VRTX) stake by 0.61% in Q1 2026, buying an estimated $1.4K and bringing the position to 494 shares worth $221K. The position accounts for 0.02% of the portfolio, ranked #331.

Onyx Bridge Wealth Group first reported a position in VRTX in Q3 2024 and has held it in 3 quarters since. The position peaked at $337K in Q3 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Onyx Bridge Wealth Group held 494 shares of Vertex Pharmaceuticals worth $221K as of Q1 2026.
  • Onyx Bridge Wealth Group bought 3 Vertex Pharmaceuticals shares in Q1 2026, an estimated $1.4K.
  • Vertex Pharmaceuticals made up 0.02% of Onyx Bridge Wealth Group's portfolio in Q1 2026, its #331 holding.
  • Onyx Bridge Wealth Group first reported a position in Vertex Pharmaceuticals in Q3 2024 and has held it in 3 quarters since.
  • Onyx Bridge Wealth Group's Vertex Pharmaceuticals position peaked at $337K in Q3 2024.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Onyx Bridge Wealth Group's 13F filing for Q1 2026, filed 22 Apr 2026.